The promoter methylation of LRP12, CDH1, BMPER and DUSP4 was 100%, 91%, 55%, and 32% across all analyzed lymphoma types included in the validation series, respectively (Table 2 and Figure 2). This evidence concerns the gene CDH1 and lymphoma.